Fluoxetine inhibited the activation of A1 reactive astrocyte in a mouse model of major depressive disorder through astrocytic 5-HT2BR/β-arrestin2 pathway
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Fluoxetine inhibited the activation of A1 reactive astrocyte in a mouse model of major depressive disorder through astrocytic 5-HT2BR/β-arrestin2 pathway ; volume:19 ; number:1 ; day:29 ; month:1 ; year:2022 ; pages:1-20 ; date:12.2022
Journal of neuroinflammation ; 19, Heft 1 (29.1.2022), 1-20, 12.2022
- Urheber
-
Fang, Yinquan
Ding, Xiao
Zhang, Yihe
Cai, Lei
Ge, Yuan
Ma, Kaiyang
Xu, Rong
Li, Shanshan
Song, Mengmeng
Zhu, Hong
Liu, Jiaqi
Ding, Jianhua
Lu, Ming
Hu, Gang
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12974-022-02389-y
- URN
-
urn:nbn:de:101:1-2022050807115445748601
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Fang, Yinquan
- Ding, Xiao
- Zhang, Yihe
- Cai, Lei
- Ge, Yuan
- Ma, Kaiyang
- Xu, Rong
- Li, Shanshan
- Song, Mengmeng
- Zhu, Hong
- Liu, Jiaqi
- Ding, Jianhua
- Lu, Ming
- Hu, Gang
- SpringerLink (Online service)
Ähnliche Objekte (12)
“Platform Amphibiousness” in Covid-19: The Construction and Communication of National Image in the Global South in the Polymedia Use of Chinese Overseas Students
A genomics-based systems approach towards drug repositioning for rheumatoid arthritis
Large-scale mining disease comorbidity relationships from post-market drug adverse events surveillance data
Context-sensitive network analysis identifies food metabolites associated with Alzheimer’s disease: an exploratory study
Data-driven multiple-level analysis of gut-microbiome-immune-joint interactions in rheumatoid arthritis
Large-scale combining signals from both biomedical literature and the FDA Adverse Event Reporting System (FAERS) to improve post-marketing drug safety signal detection
Towards understanding brain-gut-microbiome connections in Alzheimer’s disease
Mining comorbidities of opioid use disorder from FDA adverse event reporting system and patient electronic health records
Large-scale extraction of accurate drug-disease treatment pairs from biomedical literature for drug repurposing
The horizontal-to-vertical spectral ratio and its applications
Phenome-based gene discovery provides information about Parkinson’s disease drug targets
dRiskKB: a large-scale disease-disease risk relationship knowledge base constructed from biomedical text
“Platform Amphibiousness” in Covid-19: The Construction and Communication of National Image in the Global South in the Polymedia Use of Chinese Overseas Students
A genomics-based systems approach towards drug repositioning for rheumatoid arthritis
Large-scale mining disease comorbidity relationships from post-market drug adverse events surveillance data
Context-sensitive network analysis identifies food metabolites associated with Alzheimer’s disease: an exploratory study
Data-driven multiple-level analysis of gut-microbiome-immune-joint interactions in rheumatoid arthritis
Large-scale combining signals from both biomedical literature and the FDA Adverse Event Reporting System (FAERS) to improve post-marketing drug safety signal detection
Towards understanding brain-gut-microbiome connections in Alzheimer’s disease
Mining comorbidities of opioid use disorder from FDA adverse event reporting system and patient electronic health records
Large-scale extraction of accurate drug-disease treatment pairs from biomedical literature for drug repurposing
The horizontal-to-vertical spectral ratio and its applications
Phenome-based gene discovery provides information about Parkinson’s disease drug targets
dRiskKB: a large-scale disease-disease risk relationship knowledge base constructed from biomedical text
“Platform Amphibiousness” in Covid-19: The Construction and Communication of National Image in the Global South in the Polymedia Use of Chinese Overseas Students
A genomics-based systems approach towards drug repositioning for rheumatoid arthritis
Large-scale mining disease comorbidity relationships from post-market drug adverse events surveillance data
Context-sensitive network analysis identifies food metabolites associated with Alzheimer’s disease: an exploratory study
Data-driven multiple-level analysis of gut-microbiome-immune-joint interactions in rheumatoid arthritis
Large-scale combining signals from both biomedical literature and the FDA Adverse Event Reporting System (FAERS) to improve post-marketing drug safety signal detection
Towards understanding brain-gut-microbiome connections in Alzheimer’s disease
Mining comorbidities of opioid use disorder from FDA adverse event reporting system and patient electronic health records
Large-scale extraction of accurate drug-disease treatment pairs from biomedical literature for drug repurposing
The horizontal-to-vertical spectral ratio and its applications
Phenome-based gene discovery provides information about Parkinson’s disease drug targets